ArticleFrontiers in oncology2022

A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.

Yutao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.